Abstract:Multidrug and toxic compound extrusion (MATE) family transporters are conserved in the three primary domains of life (Archaea, Bacteria and Eukarya), and export xenobiotics using an electrochemical gradient of H(+) or Na(+) across the membrane. MATE transporters confer multidrug resistance to bacterial pathogens and cancer cells, thus causing critical reductions in the therapeutic efficacies of antibiotics and anti-cancer drugs, respectively. Therefore, the development of MATE inhibitors has long been awaited in the field of clinical medicine. Here we present the crystal structures of the H(+)-driven MATE transporter from Pyrococcus furiosus in two distinct apo-form conformations, and in complexes with a derivative of the antibacterial drug norfloxacin and three in vitro selected thioether-macrocyclic peptides, at 2.1-3.0 Å resolutions. The structures, combined with functional analyses, show that the protonation of Asp 41 on the amino (N)-terminal lobe induces the bending of TM1, which in turn collapses the N-lobe cavity, thereby extruding the substrate drug to the extracellular space. Moreover, the macrocyclic peptides bind the central cleft in distinct manners, which correlate with their inhibitory activities. The strongest inhibitory peptide that occupies the N-lobe cavity may pave the way towards the development of efficient inhibitors against MATE transporters.

Author Correction: Structural basis for the drug extrusion mechanism by a MATE multidrug transporter

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Author Correction: Molecular Basis for Heat Desensitization of TRPV1 Ion Channels

Author Correction: Structural insights into the activation of metabotropic glutamate receptors

Structural Basis for the Drug Extrusion Mechanism by a MATE Multidrug Transporter.

Author Correction: Mechanochemical bond scission for the activation of drugs

Publisher Correction: Molecular Basis of Vasohibins-Mediated Detyrosination and Its Impact on Spindle Function and Mitosis.

Correction: Supramolecularly Engineered Phospholipids Constructed by Nucleobase Molecular Recognition: Upgraded Generation of Phospholipids for Drug Delivery

Author Correction: Chemical genomics with pyrvinium identifies C1orf115 as a regulator of drug efflux

Author Correction: Structure of human GABAB receptor in an inactive state

Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG

Correction: Corrigendum: Autophagy-associated alpha-arrestin signaling is required for conidiogenous cell development in Magnaporthe oryzae

Author Correction: Uncovering Pharmacological Mechanisms of Wu-tou Decoction Acting on Rheumatoid Arthritis Through Systems Approaches: Drug-Target Prediction, Network Analysis and Experimental Validation.

Correction: Zheng et al. Fabrication of Co-Assembly from Berberine and Tannic Acid for Multidrug-Resistant Bacteria Infection Treatment. Pharmaceutics 2023, 15, 1782

Author Correction: Molecular mechanisms underlying the involvement of the sigma-1 receptor in methamphetamine-mediated microglial polarization

Author Correction: Constrained catecholamines gain β 2 AR selectivity through allosteric effects on pocket dynamics

Correction for “ Mechanism of E-cadherin dimerization probed by NMR relaxation dispersion

Author Correction: Structural basis for pre-tRNA recognition and processing by the human tRNA splicing endonuclease complex

Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Author Correction: A Systems Pharmacology Approach to Determine Active Compounds and Action Mechanisms of Xipayi Kuijie'an enema for Treatment of Ulcerative colitis

Author Correction: Structural basis of pH-dependent activation in a CLC transporter